Mobilization of Autologous Hematopoietic Progenitors and Subsequent Transplantation is a Safe and Feasible Procedure in Chronic Phase Chronic Myelogenous Leukemia patients presenting a Cytogenetic Resistance to Imatinib

被引:0
|
作者
Prebet, Thomas [1 ]
Tigaud, Isabelle [2 ]
Hayette, Sandrine [2 ]
Clapisson, Gilles [3 ]
Philip, Irene [3 ]
Michallet, Mauricette [1 ]
Nicolini, Franck E. [1 ]
机构
[1] Hop Edouard Herriot, Hematol Dept, 5 Pl Arsonval, F-69437 Lyon 03, France
[2] Ctr Hosp Lyon Sud, Lab Hematol & Cytogenet, Pierre Benite, France
[3] Ctr Leon Berard, Cellular Therapy & Hematopoiet Stem Cell Transpla, Lyon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:102 / 103
页数:2
相关论文
共 50 条
  • [31] Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
    Drummond, MW
    Holyoake, TL
    CANCER, 2003, 98 (08) : 1776 - 1777
  • [32] Hematopathologic and cytogenetic findings in imatinib mesylate treated chronic myelogenous leukemia patients: 2.5 years' experience
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    VOJNOSANITETSKI PREGLED, 2010, 67 (10) : 802 - 806
  • [33] BCR-ABL duplication revealed by fish analysis is frequently associated with imatinib resistance in chronic phase chronic myelogenous leukemia patients
    Rousselot, Ph.
    Mossafa, H.
    Joha, S.
    Tigaud, I.
    Rea, D.
    Corm, S.
    Hayette, S.
    Cayuela, J. M.
    Maarek, O.
    Roche-Lestienne, C.
    Terre, C.
    Lev, V.
    Preudhomme, C.
    Michallet, M.
    Calvo, F.
    Nicolini, F.
    Rousselot, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 356 - 357
  • [34] Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome
    Dayane B. Koshiyama
    Marcelo E. Z. Capra
    Giorgio A. Paskulin
    Rafael F. M. Rosa
    Ceres A. V. Oliveira
    Tito Vanelli
    Laura M. Fogliatto
    Paulo R. G. Zen
    Annals of Hematology, 2013, 92 : 185 - 189
  • [35] Prognostic Factors Associated with Complete Cytogenetic Response in Patients with Chronic Myelogenous Leukemia on Imatinib Mesylate Therapy
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (5-6) : 305 - 308
  • [36] Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome
    Koshiyama, Dayane B.
    Capra, Marcelo E. Z.
    Paskulin, Giorgio A.
    Rosa, Rafael F. M.
    Oliveira, Ceres A. V.
    Vanelli, Tito
    Fogliatto, Laura M.
    Zen, Paulo R. G.
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 185 - 189
  • [37] Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
    Sawyers, CL
    Hochhaus, A
    Feldman, E
    Goldman, JM
    Miller, CB
    Ottmann, OG
    Schiffer, CA
    Talpaz, M
    Guilhot, F
    Deininger, MWN
    Fischer, T
    O'Brien, SG
    Stone, RM
    Gambacorti-Passerini, CB
    Russell, NH
    Reiffers, JJ
    Shea, TC
    Chapuis, B
    Coutre, S
    Tura, S
    Morra, E
    Larson, RA
    Saven, A
    Peschel, C
    Gratwohl, A
    Mandelli, F
    Ben-Am, M
    Gathmann, I
    Capdeville, R
    Paquette, RL
    Druker, BJ
    BLOOD, 2002, 99 (10) : 3530 - 3539
  • [38] Persistence of Leukemia Stem Cells in Chronic Myelogenous Leukemia Patients in Complete Cytogenetic Remission on Imatinib Treatment for 5 Years
    Chu, Su
    Lin, Allen
    McDonald, Tinisha
    Snyder, David S.
    Forman, Stephen J.
    Bhatia, Ravi
    BLOOD, 2008, 112 (11) : 79 - 79
  • [39] Long term cytogenetic response after autologous transplantation in first chronic phase-chronic myeloid leukemia
    Papineschi, F
    Benedetti, E
    Caracciolo, F
    Galimberti, S
    Bulleri, M
    Favre, C
    Greco, F
    Testi, R
    Petrini, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S152 - S152
  • [40] AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
    MELONI, G
    DEFABRITIIS, P
    ALIMENA, G
    MALAGNINO, F
    MONTEFUSCO, E
    SANDRELLI, A
    PINTO, R
    VIGNETTI, M
    LOCOCO, F
    MANDELLI, F
    BONE MARROW TRANSPLANTATION, 1989, 4 : 92 - 94